Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
HLS Therapeutics Inc
T.HLS
Alternate Symbol(s):
HLTRF
Healthcare
Industrials
Auto Parts
Diversified Industrials
HLS Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on developing clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. Its products include Vascepa, Trinomia, Clozaril, CSAN Pronto, PERSERIS and MyCare Psychiatry/MyCare Insite. Its lead product, Clozaril, is an atypical...
antipsychotic indicated in the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules reduce the risk of cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or hospitalization for unstable angina in statin-treated patients with elevated triglycerides.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:HLS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(4)
•••
Imlearning
X
Comment by
Imlearning
on Jun 12, 2023 12:23pm
RE:not just one but two cantechletter.com articles
Thanks for posting this.
(1207)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Jun 12, 2023 6:48am
not just one but two cantechletter.com articles
May provide a volume lift ? HLS Therapeutics is still a buy, says Stifel It’s been a rough ride these past two years for fans of specialty pharma company HLS Therapeutics (HLS Therapeutics
...more
(36)
•••
Pat123
X
Post by
Pat123
on May 10, 2023 2:23pm
Dividend
Expecting a dividend cut tomorrow. Poorly managed co. avoid at all cost
(22)
•••
microcaptt
X
Comment by
microcaptt
on Apr 17, 2023 3:39pm
RE:Anyone following HLS still?
IMO the stock is dirt cheap. Valuation is less now than when they went public. At that time the stock valuation was primarily to the Cloz asset - they didnt even know they had a
...more
(17)
•••
rational
X
Post by
rational
on Apr 17, 2023 2:08pm
Anyone following HLS still?
BB activity really petered out here. I am still curious about this company, and I note some analysts are still expecting big things from HLS. Thoughts anyone?
(6508)
•••
retiredcf
X
Post by
retiredcf
on Apr 28, 2022 7:00am
Clarus Revise Target
4/27/2022 Clarus Securities Reiterated Rating Buy C$26.50
(6508)
•••
retiredcf
X
Post by
retiredcf
on Mar 22, 2022 6:58am
Clarus
HLS Therapeutics Reiterated by Clarus Securities C$33.00 Buy
(6508)
•••
retiredcf
X
Post by
retiredcf
on Mar 18, 2022 8:19am
Canaccord
Still looking for a double. GLTA Canaccord Genuity’s Tania Armstrong-Whitworth lowered her HLS Therapeutics Inc. target by 25 cents to $30.50 with a “buy” rating. The average is $30.58.
Thematica Insights Report and Investor Guide
Thematica: Battery Metals Report
Download our Investor’s Guide and learn how/why Battery Metals are playing a vital role in the EV Revolution.
Jeff Nielson
22 September 2023 09:28
(6508)
•••
retiredcf
X
Post by
retiredcf
on Mar 17, 2022 9:14am
NR
08:20 AM EDT, 03/17/2022 (MT Newswires) -- HLS Therapeutics Inc. (HLS.TO), a pharmaceutical company focusing on central nervous system and cardiovascular markets, on Thursday reported, in US$, that Q4
...more
(6508)
•••
retiredcf
X
Post by
retiredcf
on Dec 21, 2021 12:45pm
More Good Looking Targets
A very illiquid stock and a very quiet BB but now might be the time to start paying attention. GLTA HLS THERAPEUTICS (TSE:HLS) ANALYST RATINGS HISTORY 12/16/2021 Raymond James
...more
(6508)
•••
retiredcf
X
Post by
retiredcf
on Dec 21, 2021 12:42pm
Canaccord 2022 Top Picks
Reopening and public access to bring the pulse back Investment recommendation HLS is a specialty pharma company focused on bringing innovative central nervous system (CNS) and
...more
(658)
•••
Betteryear2
X
Post by
Betteryear2
on Aug 16, 2021 6:44am
Promotional Agreement with Pfizer for Vascepa® in Canada
Agreement enables rapid, efficient and impactful expansion to the primary care physician audience. HLS will continue to focus primarily on specialists while Pfizer will focus primarily on primary
...more
(112)
•••
wannabebuffet
X
Comment by
wannabebuffet
on Mar 17, 2021 5:35pm
RE:Q FOUR tomorrow before sunrise!
I was tempted to move out of my position into something else but with the predictions of the analysts I decided to stay in. It has made me a lot of money over the years so a few more to see how
...more
(197)
•••
pacer217
X
Post by
pacer217
on Mar 17, 2021 5:00pm
Q FOUR tomorrow before sunrise!
The BEST case estimate from "experts " on CIBC post is a Break-even Q. @ .00 cents / share. Longer term the prognosis is excellent; price guesses from $28. to above $40. within
...more
(112)
•••
wannabebuffet
X
Comment by
wannabebuffet
on Jan 19, 2021 4:59pm
RE:RE:RE:RE:preferred payout
I too did get the full amount in separate transactions a day apart. I have made a lot of money on Automodular over the years so am going to stay in for a few more years yet,
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Total revenue Increased 47% with Two +28% Dividend Increases in 6 Months – Learn More Here
Copper Exploration Company is on the Edge of a Big Discovery
Private Placement: Ready for a Golden Opportunity in Ghana and Canada?
Advanced Project Opportunities Throughout Argentina’s Lithium Triangle
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
NorthStar Gaming inks $10 million deal with Playtech to expand into the rest of Canada
Discover Lithium Recycling at the Epicentre of the Largest EV Build Out in US History